Agent for use in the case of fructose intolerance
AssigneeVitacare GmbH & Co. KG
InventorsDaniel Henry Wyrobnik, Isaac Harry Wyrobnik
Life of this patent
Estimating the term…
Abstract
There is provided in accordance with embodiments of the invention a method of treating or reducing the effects in a subject of a condition selected from fructose intolerance and impaired fructose metabolism, the method comprising administering to a subject in need of such treatment or reduction an efficacious amount of a glucose isomerase, other than in combination with 5-D-fructose dehydrogenase. Other embodiments are also disclosed.
Claims19
A method of reducing in a subject at least one of (a) the bioavailability of fructose in the body of said subject, (b) the amount of fructose available to the body of said subject and (c) the amount of fructose available to intestinal bacteria colonizing in the intestine of said subject, the subject being a person who would benefit from such reducing, the method comprising administering to the subject an amount of a glucose isomerase sufficient to effect such reducing in said subject, wherein said glucose isomerase is not administered in combination with an effective amount of 5-D-fructose-dehydrogenase.
Dependencies are inferred from the claim text.